Panagora Asset Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Panagora Asset Management’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-26,989	Closed	-$504K	–	1645
2022 Q1	$504K	Hold	26,989	–	–	﹤0.01%	1204
2021 Q4	$577K	Sell	26,989 -6,233	-19%	-$123K	﹤0.01%	1164
2021 Q3	$614K	Hold	33,222	–	–	﹤0.01%	1217
2021 Q2	$711K	Buy	+33,222	New	+$676K	﹤0.01%	1175

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Panagora Asset Management's OCDX Position: Q2 2022 in Review

Panagora Asset Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 26,989 shares — an estimated $504K sold.

Panagora Asset Management first reported a position in OCDX in Q2 2021 and held it in 4 quarters. The position peaked at $711K in Q2 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Panagora Asset Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Panagora Asset Management sold 26,989 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $504K.
Panagora Asset Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 4 quarters.
Panagora Asset Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $711K in Q2 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Panagora Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.